Ascenta Capital invests in biotechs.
Ascenta Capital was born to help innovative companies as they grow from their scientific foundations to advance the clinical development of meaningful medicines for patients. We make concentrated investments and work in collaboration to support our management teams with our strategic and operational experience.
We partner with companies that have development candidates, translating their preclinical science into early human safety and efficiency data.
We believe there lies an opportunity in multi-product platforms. Complex questions of growth, strategy, and value creation are front and center, and offer asymmetric upside.
People
- Evan Rachlin, Co-Founder & Managing Partner
You last contacted this investor on .